New drug tested to relieve debilitating itch for dialysis patients
NCT ID NCT03802617
Summary
This study tested an investigational drug called MR13A9 to see if it could safely reduce severe itching in people receiving hemodialysis for kidney disease. It involved 247 Japanese patients who experienced significant itch despite treatment. Researchers compared different doses of MR13A9 against a placebo to find the most effective and safe amount.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UREMIC PRURITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.